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Background: Individuals with premutation alleles of the FMR1 gene are at risk of
developing fragile X-associated tremor/ataxia syndrome (FXTAS), a neurodegenerative
condition affecting sensorimotor function. Information on quantitative symptom traits
associated with aging in premutation carriers is needed to clarify neurodegenerative
processes contributing to FXTAS.
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Materials and Methods: 26 FMR1 premutation carriers ages 44–77 years and 31
age-matched healthy controls completed rapid (2 s) and sustained (8 s) visually guided
precision gripping tasks. Individuals pressed at multiple force levels to determine the
impact of increasing the difficulty of sensorimotor actions on precision behavior. During
initial pressing, reaction time, the rate at which individuals increased their force, the
duration of pressing, and force accuracy were measured. During sustained gripping,
the complexity of the force time series, force variability, and mean force were examined.
During relaxation, the rate at which individuals decreased their force was measured. We
also examined the relationships between visuomotor behavior and cytosine-guanineguanine (CGG) repeat length and clinically rated FXTAS symptoms.
Results: Relative to controls, premutation carriers showed reduced rates of initial force
generation during rapid motor actions and longer durations of their initial pressing
with their dominant hand. During sustained force, premutation carriers demonstrated
reduced force complexity, though this effect was specific to younger premutation carries
during dominant hand pressing and was more severe for younger relative to older
premutation carriers at low and medium force levels. Increased reaction time and lower
sustained force complexity each were associated with greater CGG repeat length for
premutation carriers. Increased reaction time and increased sustained force variability
were associated with more severe clinically rated FXTAS symptoms.
Conclusion: Overall our findings suggest multiple sensorimotor processes are
disrupted in aging premutation carriers, including initial force control guided by
feedforward mechanisms and sustained sensorimotor behaviors guided by sensory
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feedback control processes. Results indicating that sensorimotor issues in aging
premutation carriers relate to both greater CGG repeat length and clinically rated FXTAS
symptoms suggest that quantitative tests of precision sensorimotor ability may serve as
key targets for monitoring FXTAS risk and progression.
Keywords: fragile X-associated tremor/ataxia syndrome, FMR1 premutation, sensorimotor, precision grip,
neurodegeneration, bradykinesia, dysmetria

translational measurements that comprehensively assess multiple
sensorimotor processes, including the initiation, maintenance,
and termination of behavior, are needed to define affected
systems, clarify neurobiological mechanisms of FXTAS, and
monitor both disease risk and progression.
One candidate approach for characterizing multiple
sensorimotor processes in premutation carriers is studying
visually guided precision gripping. Precision gripping is
important for many daily living activities (e.g., writing, grasping
objects), and multiple studies have documented atypical
precision gripping behavior in neurodevelopmental (Mosconi
et al., 2015; Wang et al., 2015) and neurodegenerative conditions
that affects patients’ quality of life (Vaillancourt et al., 2001a,c).
Further, the neural bases of visually guided precision gripping
have been studied extensively suggesting that clarifying spared
and affected processes may help identify key brain mechanisms
associated with different clinical conditions (Ehrsson et al.,
2000; Kuhtz-Buschbeck et al., 2008; Prodoehl et al., 2009; Neely
et al., 2013). During precision gripping, individuals initiate a
“rise phase” in which they rapidly increase their force output to
reach a target level. Due to afferent delays of sensory feedback
information, initial pressing is guided by internal action plans
and often results in initial dysmetria (e.g., overshooting at lower
force levels; undershooting at higher force levels), especially
during rapid compared to longer duration actions (Desmurget
et al., 1999; Potter et al., 2006; Wang et al., 2015). During a
subsequent “sustained phase,” individuals reactively adjust motor
output to match their target and maintain a more constant level
of force integrating feedforward and sensory feedback processes.
Increases in sustained force variability and reductions in force
complexity each implicate failures in the ability to dynamically
and reactively adjust precision motor output in response to
sensory feedback (Vaillancourt et al., 2001b; Chu and Sanger,
2009). At the end of precision gripping actions, participants
engage in a “relaxation phase” in which they rapidly release
their grip force by terminating motor unit firing within agonist
muscles supporting gripping (e.g., first dorsal interosseus) and
initiating antagonist motor unit firing.
In the present study, we systematically assessed rise, sustained,
and relaxation phases of visually guided precision gripping
in FMR1 premutation carriers ages 44–77 years. Our primary
goal was to comprehensively characterize precision sensorimotor
behaviors in aging FMR1 premutation carriers as the extent
to which initial, sustained, and relaxation phase behaviors are
impacted has not yet been assessed. Both rapid and sustained
actions were tested in order to determine the differential
impact of FMR1 premutations on sensorimotor feedforward and
feedback processes. During rapid sensorimotor tasks, greater

BACKGROUND
Fragile X syndrome is the most common heritable form of
intellectual disability, and it is caused by “full” mutations of
the FMR1 gene consisting of >200 cytosine-guanine-guanine
(CGG) repeats (Kremer et al., 1991). Premutations of the
FMR1 gene involving 55–200 CGG repeats also confer risk for
multiple subclinical issues as well as medical, psychiatric, and
neurodegenerative conditions (Lozano et al., 2014) including
fragile X-associated tremor/ataxia syndrome (FXTAS). FXTAS
is a neurodegenerative disease in which patients present with
a variety of sensorimotor, cognitive, psychiatric and medical
issues, as well as cerebellar and cortical degeneration typically
beginning at ages 50–70 years (Brunberg et al., 2002; Jacquemont
et al., 2003). The defining clinical symptoms of FXTAS include
intention tremor, gait ataxia, and Parkinsonism (Hagerman et al.,
2001; Jacquemont et al., 2003; Leehey et al., 2007; Juncos et al.,
2011), though some patients also demonstrate cognitive decline
and psychiatric issues (Grigsby et al., 2008). Pathology of the
middle cerebellar peduncle (MCP sign), cerebral atrophy, and
intranuclear inclusions also are associated with FXTAS (Brunberg
et al., 2002; Greco et al., 2006). Still, symptom presentation
is highly variable across patients, and objective, quantitative
tools are needed to identify aging premutation carriers most
at risk of developing FXTAS, track disease progression, and
determine neurobiological mechanisms (Jacquemont et al., 2004;
Leehey et al., 2007).
Prior quantitative studies have indicated that premutation
carriers with FXTAS and elderly, asymptomatic premutation
carriers each show sensorimotor issues. For example, FXTAS
patients show increased postural sway relative to healthy aging
individuals (Aguilar et al., 2008), while aging premutation
carriers with and without FXTAS each show postural sway during
standing that is associated with greater CGG repeat length (Kraan
et al., 2013; O’Keefe et al., 2015; Wang et al., 2019). Studies of fine
motor abilities critical to everyday activities have indicated that
asymptomatic FMR1 premutation carriers (Shickman et al., 2018)
and FXTAS patients (Schneider et al., 2012) show reduced motor
speed. Park et al. (2019) also reported increased force variability
during sustained finger abduction implicating feedback processes
involved in reactively adjusting ongoing precision motor
behaviors in response to sensory error information. Importantly,
Shickman et al. (2018) documented that more severe fine
motor issues were associated with greater CGG repeat length in
asymptomatic aging premutation carries, suggesting fine motor
deficits may covary with FXTAS risk. While these studies indicate
tests of fine motor control may be useful for quantifying clinical
and subclinical issues in aging premutation carriers, precise and
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demands are placed on feedforward systems responsible for
the accuracy and rapid execution of initial motor plans (Ghez
et al., 1991). During sustained sensorimotor action, the integrity
of sensorimotor feedback processes responsible for the online
translation of sensory error information into corrective motor
action is tested (Desmurget and Grafton, 2000; Vaillancourt
et al., 2003). We also assessed sensorimotor behavior across
multiple force levels, allowing us to assess the effect of increased
task requirements on precision sensorimotor behavior. By
examining a large age range, we were able to determine whether
visually guided precision gripping issues were more prominent
at relatively earlier stages of aging suggesting that they may
be prodromal markers of degeneration, or whether they may
become more prominent later suggesting decline at advanced
ages. Gripping was tested across both hands to determine if
neurodegenerative processes associated with aging in FMR1
premutation carriers may be lateralized as previously suggested
(Przybyla et al., 2011; Raw et al., 2012). We also examined
the relationship between sensorimotor outcomes, FXTAS clinical
symptoms, and CGG repeat length to determine the utility
of our measures for characterizing sensorimotor deterioration
associated with the severity of and risk for FXTAS.

that could cause atypical sensorimotor functioning or a history
of medications known to affect sensorimotor functioning,
including antipsychotics, stimulants, or benzodiazepines
(Reilly et al., 2008).
FMR1 premutation carriers were identified through local
fragile X clinics and postings on local and national fragile
X association LISTSERVs. Control participants were recruited
through community advertisements. This study was carried
out in accordance with the recommendations of and was
approved by the University of Texas Southwestern Medical
Center Institutional Review Board. All subjects provided written
informed consent after a complete description of the study in
accordance with the Declaration of Helsinki.

Neurological Evaluations
FMR1 premutation carriers completed a clinical exam by a
neurologist with expertise in movement control in aging (PK).
The clinical exam included administration of the International
Cooperative Ataxia Rating Scale (Trouillas et al., 1997). The
ICARS is comprised of 19 sections examining postural and
gait disturbances, ataxia, dysarthria, and oculomotor behavior.
Higher scores indicate more severe neuromotor issues. The
ICARS has been validated previously for diagnosis of ataxia
in patients with focal cerebellar lesions (Schoch et al., 2007),
hereditary spinocerebellar and Friedrich’s ataxia (SchmitzHubsch et al., 2006). Nine premutation carriers did not complete
the clinical evaluation due to scheduling difficulties. For the 17
premutation carriers who completed the clinical visit, ICARS
scores are presented in Table 1.

MATERIALS AND METHODS
Participants
Twenty-six premutation carriers and 31 healthy controls
completed sensorimotor testing (Table 1). Controls and
carriers did not differ on age, sex ratio, or handedness.
No premutation carriers had an existing diagnosis of any
neurological disorder, nor did they self-report any motor (e.g.,
gait ataxia, intention tremor) or memory issues. Controls were
excluded for current or past neurodegenerative, neurological,
or major psychiatric disorders (e.g., schizophrenia, bipolar
disorder). Controls also were excluded for a family history of
fragile X syndrome or intellectual/developmental disabilities
in first- or second-degree relatives. Participants were excluded
if they reported any neurological or musculoskeletal disorder

Sensorimotor Testing
Participants completed two tests of sensorimotor behavior
differentiated by the trial duration and inter-trial interval (“rapid”
trials included 2 s of pressing alternating with 2 s of rest, and
“sustained” trials included 8 s of pressing alternating with 8 s
of rest). For both tests, stimuli were presented on a 102 cm (40
inches) Samsung LCD monitor with a resolution of 1366 × 768
and a 120 Hz refresh rate. Participants were tested in a darkened
room while seated 52 cm from the display monitor with their

TABLE 1 | Demographic and clinical characteristics.
Controls (n = 31)

Premutation carriers (n = 26)

t

p

Age (years)

53 (10)

57 (9)

Age range (years)

40–73

44–77

–

–

Sex (% male)†

39%

23%

1.60†

0.206

Handedness (% right)†

90%

96%

0.74†

0.391

109 (13)

99 (12)

2.93

0.005∗∗

Dominant hand MVC

87 (28)

77 (23)

1.42

0.161

Non-dominant hand MVC

84 (32)

82 (27)

0.24

0.811

ICARS total score

–

5 (5)

–

–

ICARS total range

–

0–19

–

–

CGG repeat length

–

82 (17)

–

–

CGG repeat length range

–

55–110

–

–

FSIQ

−1.39

0.169

FSIQ: full-scale IQ; ICARS: International Cooperative Ataxia Rating Scale; CGG: cytosine-guanine-guanine. Variables are presented as: mean (SD); ∗∗ p < 0.01; † chi-square
statistic; a group by hand interaction of MVC is reported in Table 2.

Frontiers in Integrative Neuroscience | www.frontiersin.org

3

October 2019 | Volume 13 | Article 56

McKinney et al.

Motor Control in Premutation Carriers

elbow at 90◦ and their forearm resting in a relaxed position on
a custom-made arm brace. The arm brace was clamped to a table
to keep the participant’s arm position stable throughout testing
(Figure 1). The participant’s hand was pronated and lay flat with
digits comfortably extended. Participants used their thumb and
index finger to press against two opposing precision load cells
(ELFF-B4-100N; Entran) 1.27 cm in diameter secured to a custom
grip device attached to the arm brace. A Coulbourn (V72-25)
resistive bridge strain amplifier received analog signal from the
load cells. Data were sampled at 200 Hz with a 16-bit analog-todigital converter (DI-720; DATAQ Instruments) and converted
to Newton of force using a calibration factor derived from known
weights before the study (Mosconi et al., 2015).

pressing at the beginning of each trial (Figure 2). Participants
received two instructions: (1) press the load cells as quickly
as possible when the red target bar turns green, and (2) keep
pressing so that the force bar stays as steady as possible at the
level of the green target bar. These instructions were identical for
the two versions of the task described below.
“Rapid” (2 s) and “sustained” (8 s) trials were administered
at 15, 45, and 85% of each individual’s MVC. During the rapid
test, two blocks of five trials were presented for each hand at
each force level (2 hands × 3 force levels × 2 blocks × 5
trials = 60 rapid trials). Each 2 s rapid trial alternated with 2 s
rest periods. A 15 s rest block was provided after each block
of trials. During the sustained test, participants completed two
blocks of three trials for each hand at each force level (2 hands × 3
force levels × 2 blocks × 3 trials = 36 sustained trials). Eight
seconds trials were followed by 8 s rest periods, and each block
was separated by 15 s of rest. For both tests, the same hand was
never tested on consecutive blocks. The order of force levels was
randomized across blocks. The order of the two experiments was
randomly assigned to each participant. Participants self-reported
their dominant hand.

Procedures
Before testing, each participant’s maximum voluntary contraction
(MVC) was calculated separately for each hand using the average
of the maximum force output during three trials in which
participants pressed as hard as they could for 3 s.
During sensorimotor testing, participants viewed a horizontal
white force bar that moved upward with increased force and
downward with decreased force and a static target bar that was
red during rest and turned green to cue the participant to begin

Sensorimotor Data Processing
Force traces for each trial were low-pass filtered via a double-pass
4th-order Butterworth filter at a cutoff of 15 Hz in MATLAB.
Data were analyzed using custom MATLAB scripts previously
developed by our lab (Wang et al., 2015).
Data from three distinct phases were analyzed. During the
initial rise phase in which individuals pressed on the load cells
to reach the target level, we examined reaction time, peak rate of
force increase (i.e., the maximum value of the first derivative of
the force trace), the duration of the period in which individuals
increased their force, and the accuracy of their initial force output.
The onset of the rise phase was calculated as the time at which
the rate of force increase first exceeded 5% of the peak rate of
force increase and remained above this level for at least 100 ms
(Grafton and Tunik, 2011; Wang et al., 2015). Reaction time was
calculated as the difference between rise phase onset and the
appearance of the start cue. The rise phase offset was calculated
as the time-point when the rate of force increase fell below
5% of the peak rate of force increase, and the force level was
within 90–110% of the mean force of the sustained phase (Wang
et al., 2015). The peak rate of force increase was defined as the
maximum value of the first derivative of the force trace. Rise
phase duration was then calculated as the difference between

FIGURE 2 | Sensorimotor test stimuli. Participants pressed when the red bar
turned green in order to move the white bar up to the target green bar. They
were instructed to maintain their force level at the level of the green bar as
steadily as possible.

FIGURE 1 | The custom-made arm brace and load cells for precision grip
testing. Participants pressed with their thumb and forefinger against two
precision load cells while viewing two horizontal bars displayed vertically on
the screen.
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the rise phase offset and rise phase onset. Rate of force increase
and duration of initial force output were analyzed relative to rise
phase force output to account for differences in force kinetics
attributable to differences in force amplitude. Force accuracy for
the rise phase was calculated as the force at rise offset divided
rise )
by the target force (i.e., Rise Accuracy = (F(Ftarget
) ). Values below
1 represent an undershooting of the target force and values
above 1 reflect overshooting of the target force. An accuracy
score of 1 indicates perfect accuracy. The entire rise phase was
excluded if participants began gripping before the start cue, or
if they returned to baseline prior to reaching 90% of the target
force. Rise phase data for both the rapid and sustained tasks
were analyzed within the same model to allow for the analysis
of task effects (i.e., rapid vs. sustained). Consistent with prior
studies, participants were expected to show faster reaction times,
more rapid increases in force, shorter rise phase duration and
reduced accuracy during rapid compared to sustained actions
(Wang et al., 2015).
To determine the extent to which participants could maintain
a constant level of force using visual feedback, the sustained
phase was examined and defined as the period following rise
phase offset and prior to the appearance of the stop cue. Due to
the brief duration of rapid trials, the sustained phase was only
examined during 8 s trials. The mean force of the time series was
calculated to determine individuals’ ability to complete the task.
The variability of the force time series was calculated using the
following procedures: first, force data were linearly detrended to
account for systematic changes in mean force over the course
of the trial (e.g., data drift). Second, the within-trial standard
deviation (SD) of the force time series was calculated. To examine
the time-dependent structure of the time series, the approximate
entropy (ApEn) was calculated for each trial (Slifkin and Newell,
1999; Vaillancourt et al., 2001b). ApEn returns a value between
0 and 2, reflecting the predictability of future values in a time
series based on previous values. For example, a sine wave has
accurate short- and long-term predictability, corresponding to
an ApEn value near 0. High irregularity of the data, reflective
of the independence of each force value, returns an ApEn near
2. The algorithm and parameter settings for these calculations
(m = 2; r = 0.2 × SD of the signal) were identical to previous work
(Vaillancourt and Newell, 2000). Sustained phase variables were
excluded if fewer than 4 s of data were available or if participants
returned to baseline for more than 1 s (e.g., a > 1 s dip of
the force signal).
In order to determine the rate at which individuals released
force at the end of trials, the relaxation phase also was examined.
The onset of the relaxation phase was defined as the first point
following the stop cue (target bar turned red) at which velocity
(i.e., rate of change of force) went below 5% of the peak velocity
and remained at that level or below for at least 100 ms. The
offset of the relaxation phase was defined as the first point at
which velocity rose back above 5% of the peak relaxation velocity.
We examined the rate of force decrease during the relaxation
phase. The peak rate of force decrease was identified as the
minimum value of the first derivative of the force trace following
the stop cue. To control for differences in force level prior to
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force release, the rate of force decrease was examined relative to
force amplitude prior to relaxation. Rate of force relaxation was
not examined if the participant released force prior to the stop
cue. Relaxation phase data was examined for both the rapid and
sustained tasks in the same model.

CGG Repeat Count
All premutation carriers provided blood samples to confirm
premutation status. FMR1 CGG repeat count was quantified
using molecular testing conducted at Dr. Elizabeth BerryKravis’ Molecular Diagnostic Laboratory at Rush University.
Genomic DNA was isolated from peripheral blood leukocytes
samples. The FMR1 polymerase chain reaction (PCR) test with
quantification of allele-specific CGG repeat count was performed
using commercially available kits (Asuragen, Inc., Austin, TX,
United States). For women, CGG repeat analyses reflect the
longest CGG repeat of the two alleles.

Cognitive Measures
Cognitive functioning was assessed using the abbreviated battery
of the Stanford-Binet Intelligence Scales, Fifth Edition (SB-5)
including non-verbal fluid reasoning and verbal knowledge subsections (Roid, 2003). One participant did not complete the SB-5
because they were not fluent in English. Healthy controls had
significantly higher full-scale IQs (M = 109.3, SD = 12.8) than
premutation carriers (M = 99.5, SD = 12.1), t(54) = 2.93, p < 0.01,
though IQ was in the average range for both groups (Table 1).

Statistical Analyses
To determine whether sensorimotor ability differed according
to premutation carrier status, linear multilevel mixed effect
(MLM) analyses were conducted (Bates et al., 2015; Koller,
2016). This approach allows for the simultaneous analysis of
within- and between-subject fixed effects while allowing withinsubject factors to differ for each participant as random effects.
This approach also allows for the analysis of interactions
within the repeated measures design including participants with
missing data (e.g., failed to complete dominant hand trials
at 85% MVC) without listwise deletion of that participant.
Task (rapid vs. sustained) and condition effects (percent MVC,
hand) were identified as level 1 predictors and subject effects
(group, age) were identified as level 2 predictors. Random
variance components for the intercept (subject) also were
analyzed. To maintain relatively parsimonious models, fiveway interactions were not analyzed. Initial models included all
two-, three-, and four-way interactions, after which variables
and interactions were removed and model fit was compared
between the previous and current models using a likelihood
ratio test. Only variables which significantly (p < 0.05) improved
model fit were incorporated into final models. Non-normally
distributed variables were log-transformed. Final models used
robust linear mixed effect modeling to provide more stringent
fixed effect estimates and standard errors while reducing the
impact of outliers (Pinheiro et al., 2001). Due to concerns
with Type 1 error when interpreting robust estimates with
traditional p-value cut-offs, we followed best practice guidelines
and significant results are reported if |t| ≥ 1.96 (Luke, 2017). Age
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target amplitude (i.e., force level at the end of the rise phase),
rate of force increase also was reduced at higher compared
to lower MVC target levels (15% vs. 45% MVC: β = −0.22,
SE = 0.04, p < 0.001, partial R2 = 0.050; 15% vs. 85% MVC:
β = −0.34, SE = 0.04, p < 0.001, partial R2 = 0.104). Rate of
force increase was greater with the non-dominant compared to
the dominant hand (β = 0.10, SE = 0.02, p < 0.001, partial
R2 = 0.025) and slowed with age (β = −0.07, SE = 0.03, p = 0.042,
partial R2 = 0.049).
Premutation carriers showed a reduced rate of force increase
relative to controls during the rapid but not the sustained task
(Figure 4; group × task: β = 0.13, SE = 0.04, p = 0.004,
partial R2 = 0.009).

was centered for all models, and each categorical predictor was
dummy coded with the following conditions serving as baseline
references: healthy controls, 15% MVC, dominant hand, rapid
(2 s) task. Based on these references, the intercept for each
model was interpreted as the predicted value of the dependent
outcome for an average aged (54.87 years) healthy control
during the 15% MVC dominant hand rapid task. Predicted
values are then obtained by adding the relevant fixed effect and
interaction estimates. Main effect and interaction effect results
are reported relative to baseline reference values. Due to the
MVC manipulation having three levels, MVC percent main
and interaction effects are presented separately for 45 and 85%
MVC relative to the 15% MVC reference condition. Significant
task and age effects are reported followed by group and group
interaction effects. Mixed effect modeling was conducted using
the robustlmm and lmer packages within R version 3.6.0 (Bates
et al., 2015; Koller, 2016).
Due to the non-normal distribution of CGG repeat length and
ICARS scores, the relationships between sensorimotor outcomes,
ICARS scores, and CGG repeat length were examined using
Spearman’s rank-order correlations. Linear regression was used
to determine if total ICARS scores were related to age, CGG
repeat length, or the interaction of age and CGG repeat length.
Due to the large number of correlations that were performed,
only results with p < 0.01 were interpreted as significant.
Correlational and regression analyses were conducted using IBM
SPSS Statistics 25.

Rise Phase Duration
For all participants, rise phase duration was greater during the
rapid compared to the sustained task (Table 4; β = −0.31,
SE = 0.02, p < 0.001, partial R2 = 0.214) and was increased at
higher compared to lower MVC target levels (15% vs. 45% MVC:
β = −1.04, SE = 0.02, p < 0.001, partial R2 = 0.680; 15% vs. 85%
MVC: β = −1.59, SE = 0.02, p < 0.001, partial R2 = 0.831).
Relative to controls, premutation carriers showed longer rise
phase durations, but only for their dominant hand (Figure 5;
group × hand: β = −0.12, SE = 0.04, p = 0.001, partial R2 = 0.011).

Rise Phase Accuracy
Across tasks, participants overshot target force levels at 15%
MVC (M = 1.05; SD = 0.14), showed greater accuracy at
45% MVC (M = 0.99; SD = 0.04), and then undershot target
force level at 85% MVC (M = 0.96; SD = 0.05). During
the rapid task, participants demonstrated greater levels of
overshooting compared to the sustained task at 15% MVC
(β = −0.02, SE = 0.01, p = 0.001, partial R2 = 0.039) but
similar accuracy at 45% (15% vs. 45% MVC × task: β = 0.01,
SE = 0.01, p = 0.150, partial R2 = 0.016) and 85% MVC
(15% vs. 85% MVC × task: β = 0.02, SE = 0.01, p = 0.062,
partial R2 = 0.017).
There were no significant group differences or group
interactions for rise phase accuracy.

RESULTS
Maximum Voluntary Contraction
Relative to controls, premutation carriers showed a greater
difference between their dominant and non-dominant hand
MVC (Figure 3 and Tables 1, 2; group × hand: β = 7.16,
SE = 3.47, p = 0.039, partial R2 = 0.010). MVC was not related
to age (β = −2.01, SE = 4.00, p = 0.616, partial R2 = 0.029),
and the relationship between age and MVC did not differ
between groups (group × age: β = 6.47, SE = 6.28, p = 0.303,
partial R2 = 0.055).

Sustained Phase

Rise Phase

ApEn

Reaction Time

Participants demonstrated reduced ApEn at higher compared to
lower target force levels (Table 5; 15% vs. 45% MVC: β = −0.06,
SE = 0.02, p < 0.001, partial R2 = 0.136; 15% vs. 85% MVC:
β = −0.13, SE = 0.02, p < 0.001, partial R2 = 0.026).
Premutation carriers showed reduced ApEn relative to
controls, and this group difference varied as a function of age
and target force level (Figure 6; group × age × 15% vs. 45%
MVC: β = −0.001, SE = 0.0, p = 0.960, partial R2 < 0.001;
group × age × 15% vs. 85% MVC: β = −0.06, SE = 0.02,
p = 0.008, partial R2 = 0.010). Reduced ApEn in premutation
carriers relative to controls was more severe at younger ages
during the 15 and 45% MVC conditions but not for the 85%
MVC condition. Premutation carriers also showed reduced
ApEn that varied as a function of age and hand (Figure 7;
group × hand × age: β = −0.05, SE = 0.02, p = 0.011, partial

Participants showed shorter reaction times during the rapid task
relative to the sustained task (Table 3; β = 0.14, SE = 0.02,
p < 0.001, partial R2 = 0.050). Reaction time increased with
increases in target MVC percent (15% vs. 45% MVC: β = 0.10,
SE = 0.02, p < 0.001, partial R2 = 0.015; 15% vs. 85% MVC:
β = 0.17, SE = 0.02, p < 0.001, partial R2 = 0.036) and age (β = 0.10,
SE = 0.04, p = 0.014, partial R2 = 0.074).
No significant group differences or group interactions were
identified for reaction time.

Rate of Force Increase
Participants demonstrated a higher rate of force increase during
the rapid compared to the sustained task (Table 3; β = −0.16,
SE = 0.04, p < 0.001, partial R2 = 0.015). After controlling for
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FIGURE 3 | Maximum voluntary contract (MVC) as a function of group and hand. Relative to controls, premutation carriers showed a greater difference between
their dominant and non-dominant hand MVC.
TABLE 2 | Best fitting multilevel models for subject MVC.
Fixed effect estimates
MVC

Estimate (SE)

Partial R2

t

Level 1 variables
Intercept

83.93 (4.20)

19.96∗

Hand

−3.59 (2.34)

−1.53

0.003

−8.30 (6.23)

−1.33

0.031

−

Level 2 variables
Group
Interaction variables
2.07∗

0.010

80.68 (8.98)

−

–

440.24 (20.98)

−

–

Group × hand
Random effect variances

7.16 (3.46)
Variance (SD)

Level 1 residual (εit )
Level 2 intercept (µ0i )

< 0.05 using the t-as-z approach; MVC: maximum voluntary contraction; partial R2 reflects the proportion of residual variation accounted for by the fixed effect when
added to the same model without the fixed effect.

∗p

R2 = 0.010). Specifically, premutation carriers showed reduced
ApEn across age for the non-dominant hand, but this effect
was more severe at younger ages relative to older ages for
the dominant hand.

Frontiers in Integrative Neuroscience | www.frontiersin.org

Force SD
Force SD scaled with target MVC level (Table 5; 15% vs. 45%
MVC: β = 0.09, SE = 0.06, p < 0.001, partial R2 = 0.250; 15% vs.
85% MVC: β = 2.00, SE = 0.06, p < 0.001, partial R2 = 0.631).
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TABLE 3 | Best fitting multilevel models for reaction time and rise phase rate of force increase.
Fixed effect estimates
Reaction time

Estimate (SE)

t

Partial R2

Level 1 variables
−1.08 (0.04)

−24.01∗

15% vs. 45% MVC

0.10 (0.02)

4.62∗

0.015

15% vs. 85% MVC

0.17 (0.02)

7.65∗

0.036

Task

0.14 (0.02)

7.97∗

0.050

0.10 (0.04)

2.47∗

0.074

Intercept

–

Level 2 variables
Age
Random effect variances

Variance (SD)

Level 1 residual (εit )

0.05 (0.22)

−

–

Level 2 intercept (µ0i )

0.09 (0.30)

−

–

Estimate (SE)

t

Partial R2

Fixed effect estimates
Rate of force increase

Level 1 variables
Intercept (15% MVC)

1.70 (0.05)

31.53∗

–

15% vs. 45% MVC

−0.22 (0.04)

−6.03∗

0.050

15% vs. 85% MVC

−0.34 (0.04)

−9.14∗

0.104

0.10 (0.02)

4.43∗

0.025

−0.16 (0.04)

−3.79∗

0.015

Group

−0.13 (0.07)

−1.86

0.025

Age

−0.07 (0.03)

−2.03∗

0.049

0.13 (0.04)

2.91∗

0.010

15% vs. 45% MVC × task

−0.11 (0.05)

−2.17∗

0.008

15% vs. 85% MVC × task

−0.13 (0.05)

−2.39∗

0.009

Hand
Task
Level 2 variables

Interaction variables
Group × task

Random effect variances

Variance (SD)

Level 1 residual (εit )

0.07 (0.27)

−

–

Level 2 intercept (µ0i )

0.05 (0.23)

−

–

∗ p < 0.05 using the t-as-z approach; MVC: maximum voluntary contraction; partial R2 reflects the proportion of residual variation accounted for by the fixed effect when
added to the same model without the fixed effect.

partial R2 = 0.219) and during rapid compared to sustained force
trials (β = −0.071, SE = 0.01, p < 0.001, partial R2 = 0.065).
There were no significant group differences or group
interactions for rate of force decrease.

There were no significant group differences or group
interactions for force SD.

Mean Force
Mean sustained force scaled with target MVC level (Table 5;
15% vs. 45% MVC: β = 1.08, SE = 0.01, p < 0.001, partial
R2 = 0.677; 15% vs. 85% MVC: β = 1.68, SE = 0.01, p < 0.001,
partial R2 = 0.840) and was reduced in the non-dominant relative
to the dominant hand (β = −0.05, SE = 0.01, p < 0.001,
partial R2 = 0.004).
Compared to controls, premutation carriers demonstrated
lower mean force with their dominant hand only (group × hand:
β = 0.08, SE = 0.02, p < 0.001, partial R2 = 0.007).

Sensorimotor Behavior and
Clinical/Demographic Outcomes
Age
Increased age was significantly associated with more severe
ICARS rated FXTAS symptoms (F(1,15) = 9.858, p = 0.007,
R2 = 0.397). CGG repeat length was not associated with FXTAS
symptoms (F1(1,14) = 1.891, p = 0.191, R2 1 = 0.072).

CGG Repeat Length

Relaxation Phase

Greater CGG repeat length was associated with reduced
dominant hand ApEn in the 45% MVC condition (Figure 8A
and Table 6; ρ = −0.529, p = 0.009). Greater CGG repeat length
also was associated with increased dominant hand reaction time
during the rapid task at 15% MVC (ρ = 0.543, p = 0.007). No other
sensorimotor variables were associated with CGG repeat length.

Rate of Force Decrease
During the relaxation phase, participants decreased their force
level more slowly during higher relative to lower target force
levels (15% vs. 45% MVC: β = −0.10, SE = 0.01, p < 0.001, partial
R2 = 0.079; 15% vs. 85% MVC: β = −0.19, SE = 0.01, p < 0.001,
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FIGURE 4 | Peak rate of force increase (relative to initial force output) as a function of group and task. Relative to controls, premutation carriers show a reduced rate
of force increase during rapid pressing.

implicating atypical lateralized degeneration of neuromuscular
systems in aging carriers of FMR1 premutation alleles. Second,
aging premutation carriers demonstrated a reduced ability to
rapidly increase force during precision gripping suggesting
alterations in feedforward sensorimotor control systems. Third,
younger premutation carriers demonstrated reduced complexity
of their sustained force output (i.e., ApEn), suggesting the ability
to dynamically adjust motor output in response to sensory
feedback may be impacted, especially during initial stages of
aging during which premutation carriers first become vulnerable
to FXTAS-associated deterioration. Last, multiple impairments
of sensorimotor behavior were associated with CGG repeat
length and clinically rated neuromotor issues in premutation
carriers indicating that select precision measures of sensorimotor
behavior may covary with FXTAS risk or progression.

Clinical Symptoms
More severe FXTAS symptoms were associated with greater
reaction times during the rapid task in the dominant hand 45%
MVC condition (Figure 8B and Table 7; ρ = 0.700, p = 0.002),
dominant hand 85% MVC condition (ρ = 0.665, p = 0.005),
and non-dominant hand 85% MVC condition (ρ = 0.674,
p = 0.003). More severe FXTAS symptoms also were associated
with greater reaction times during the dominant hand 15%
MVC condition of the sustained task (ρ = 0.612, p = 0.009).
More severe ICARS scores were associated with higher force SD
during the non-dominant hand 45% MVC condition (Figure 8C;
ρ = 0.663, p = 0.004).

DISCUSSION
Despite sensorimotor impairments being central to the diagnosis
of FXTAS, few studies have quantified precision sensorimotor
behaviors in aging FMR1 premutation carriers. Here, we
examined multiple distinct component processes of precision
sensorimotor behavior in aging premutation carriers in order
to identify both spared and affected systems. Four key findings
are documented. First, dominant hand strength was reduced
relative to non-dominant hand strength in premutation carriers

Frontiers in Integrative Neuroscience | www.frontiersin.org

Reduced MVC in Aging FMR1
Premutation Allele Carriers
Although premutation carriers and healthy controls did not
differ on overall strength (i.e., MVC) or mean force output,
premutation carriers showed a greater difference between their
dominant and non-dominant hand MVC and mean force
relative to controls. It is possible that premutation carriers show
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TABLE 4 | Best fitting multilevel models for rise phase duration and accuracy.
Fixed effect estimates
Rise phase duration

Estimate (SE)

t

Partial R2

Level 1 variables
−2.43 (0.06)

−38.86∗

−

15% vs. 45% MVC

−1.04 (0.02)

−46.72∗

0.680

15% vs. 85% MVC

−1.59 (0.02)

−71.98∗

Intercept

0.04 (0.02)

Hand

−0.31 (0.02)

Task

1.64
−17.11∗

0.831
0.002
0.214

Level 2 variables
0.15 (0.09)

Group

1.62

0.025

−3.28∗

0.011

Interaction variables
−0.12 (0.04)

Group × hand
Random effect variances

Variance (SD)

Level 1 residual (εit )

0.05 (0.23)

−

–

Level 2 intercept (µ0i )

0.10 (0.32)

−

–

Estimate (SE)

t

Partial R2

Fixed effect estimates
Rise accuracy

Level 1 variables
1.04 (0.45 × 10−2 )

Intercept (15% MVC)

232.14∗

–

15% vs. 45% MVC

−0.04 (0.01)

−7.22∗

0.076

15% vs. 85% MVC

−0.07 (0.01)

−12.66∗

0.144

Task

−0.02 (0.01)

−3.29∗

0.039

Interaction variables
15% vs. 45% MVC × task

0.01 (0.01)

1.44

0.016

15% vs. 85% MVC × task

0.02 (0.01)

1.86

0.017

Random effect variances

Variance (SD)

Level 1 residual (εit )

0.18 × 10−2 (0.04)

−

–

Level 2 intercept (µ0i )

0.01 × 10−2 (0.01)

−

–

< 0.05 using the t-as-z approach; MVC: maximum voluntary contraction; Partial
added to the same model without the fixed effect.
∗p

R2

et al., 2014) may be evident in some asymptomatic aging
premutation carriers during actions that require rapid increases
in force. Similar reductions in initial force production also
have been reported in studies of Parkinson’s disease suggesting
basal ganglia circuit functions may be affected during aging in
FMR1 premutation carriers (Stelmach and Worringham, 1988;
Fellows et al., 1998). This hypothesis is supported by studies
highlighting increased iron deposition in neuronal and glial cells
in putamen nuclei of FXTAS patients (Ariza et al., 2017) and
case studies documenting pre- and post-synaptic nigrostriatal
dysfunction (Zuhlke et al., 2004; Scaglione et al., 2008; Healy
et al., 2009). Our findings also could reflect peripheral alterations.
As suggested by our findings of increased lateralization of MVC
in premutation carriers, atypical recruitment of motor neurons
during voluntary muscle contractions is possible (Rose and
McGill, 2005; Wang et al., 2017; Park et al., 2019). For example,
a previous study has documented slower nerve conduction
velocities and F-wave latencies in male premutation carriers
with and without FXTAS (Soontarapornchai et al., 2008). EMG
abnormalities, including reduced motor unit firing rates, have
been reported in premutation carriers and FXTAS patients,
indicating that difficulties generating force also may stem from

degeneration of neuromuscular systems as suggested by previous
findings documenting reduced motor unit firing rates (Park
et al., 2019). Findings that MVC reductions in premutation
carriers may be more prominent in the dominant relative to the
non-dominant hand suggest that neuromotor deterioration may
be lateralized initially during aging or during initial stages of
FXTAS. Few studies have examined lateralization of sensorimotor
behavior in aging FMR1 premutation carriers or patients with
FXTAS, but longitudinal studies tracking neuromuscular strength
across both dominant and non-dominant hands are warranted.

Rapid Force Production in Aging FMR1
Premutation Allele Carriers
Reduced rates and increased durations of initial force output in
aging premutation carriers together suggest impairment in the
ability to rapidly increase force during precision sensorimotor
actions. These findings likely are not attributable to diminished
overall force output as we controlled for the overall amount
of individuals’ force generation. Instead, premutation carriers
appear to have a reduced ability to rapidly generate force,
suggesting that the bradykinesia associated with FXTAS (Niu
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TABLE 5 | Best fitting multilevel models for sustained phase variables.
Fixed effect estimates
ApEn

Estimate (SE)

t

Partial R2

Level 1 variables
0.51 (0.02)

30.06∗

–

15% vs. 45% MVC

−0.05 (0.02)

−3.63∗

0.136

15% vs. 85% MVC

−0.13 (0.02)

−8.47∗

0.026

Hand

−0.01 (0.01)

−0.51

0.001

Group

−0.03 (0.03)

−1.22

0.004

Age

−0.01 (0.02)

−0.74

0.002

Group × 15% vs. 45% MVC

0.03 × 10−2 (0.02)

0.01

<0.001

Group × 15% vs. 85% MVC

0.03 (0.02)

1.28

0.002

−0.01 (0.02)

−0.46

0.001

0.05 (0.03)

1.95

0.014

15% vs. 45% MVC × age

−0.01 (0.01)

−0.90

0.002

15% vs. 85% MVC × age

0.02 (0.01)

1.36

0.003

Hand × age

0.03 (0.01)

2.26∗

0.011

−0.05 (0.02)

−2.54∗

0.010

−0.05

<0.001

−2.67∗

0.010

0.01 (0.08)

−

–

0.38 × 10−2 (0.06)

−

–

t

Partial R2

Intercept

Level 2 variables

Interaction variables

Group × hand
Group × age

Group × hand × age
Group × age × 15% vs. 45% MVC

−0.12 ×

Random effect variances

Variance (SD)

Level 1 residual (εit )
Level 2 intercept (µ0i )
Fixed effect estimates

Estimate (SE)

Level 1 Variables
Intercept (15% MVC)

−1.17 (0.06)

−18.46∗

15% vs. 45% MVC

0.09 (0.06)

15.55∗

0.250

15% vs. 85% MVC

2.00 (0.06)

33.71∗

0.631

0.01 (0.08)

−

–

0.33 × 10−2 (0.06)

−

–

Estimate (SE)

t

Partial R2

Random effect variances

–

Variance (SD)

Level 1 residual (εit )
Level 2 intercept (µ0i )
Fixed effect estimates
Mean force

(0.02)

−0.06 (0.02)

Group × age × 15% vs. 85% MVC

Force SD

10−2

Level 1 variables
2.53 (0.05)

47.52∗

-

15% vs. 45% MVC

1.07 (0.01)

83.75∗

0.677

15% vs. 85% MVC

1.68 (0.01)

131.09∗

0.840

−0.05 (0.01)

−3.41∗

0.004

−0.10 (0.08)

−1.28

0.015

Intercept

Hand
Level 2 variables
Group
Interaction variables

0.08 (0.02)

Group × hand
Random effect variances

3.91∗

0.007

Variance (SD)

Level 1 residual (εit )

0.01 (0.28)

−

–

Level 2 intercept (µ0i )

0.08 (0.28)

−

–

< 0.05 using the t-as-z approach; MVC: maximum voluntary contraction; Partial
added to the same model without the fixed effect.

∗p
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FIGURE 5 | Rise phase duration (relative to initial force output) as a function of group and hand. Relative to controls, premutation carriers showed an increased time
to reach target force levels when using their dominant hand but not their non-dominant hand.

and reflects individuals’ ability to integrate multiple sensory
feedback and feedforward processes and update internal action
representations that guide the precision of sensorimotor output
during sustained behavior. Lower complexity suggests reduced
integration of these distinct processes and reduced ability to
update precision sensorimotor behavior to meet task demands.
Our finding that the severity of ApEn reductions in premutation
carriers is relatively similar in magnitude across ages for the
non-dominant hand, but more prominent at younger ages for
the dominant hand indicates that deterioration of sustained
sensorimotor behavior may be lateralized in aging premutation
carriers. More specifically, our results suggest that healthy

alterations at the neuromuscular level including reduced rates of
motor unit recruitment (Lechpammer et al., 2017; Bravo et al.,
2018; Park et al., 2019).

Sustained Sensorimotor Control in Aging
FMR1 Premutation Allele Carriers
During sustained force contractions, FMR1 premutation carriers
showed lower time series complexity (reduced ApEn), especially
at lower force levels and at younger ages, reflecting a reduced
ability to dynamically adjust force output in response to sensory
feedback. Increased complexity of force output is adaptive
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FIGURE 6 | Approximate entropy (ApEn; i.e., force complexity) as a function of group,% MVC, and age (linear fit with 95% confidence intervals). During the 15% and
45% MVC conditions, younger premutation carriers demonstrated reduced force complexity relative to controls, while premutation carriers and controls showed
similar levels of force complexity across age at 85% MVC.

generate rhythmic output. Corticomotor neurons demonstrate
preferred discharge frequencies, and so the use of a larger
number of neural oscillators to generate motor output would
result in greater complexity of motor output as each neural
oscillator contributes output of a different frequency (McAuley
and Marsden, 2000). Likewise, fewer neural oscillators generating
motor output would result in the reduced variability of motor
output timing consistent with a less complex and more rhythmic
force output (McAuley and Marsden, 2000; Vaillancourt et al.,
2001b). Our findings of reduced ApEn in younger premutation
carriers thus implicate atypical integration of neural oscillators
that may contribute to increased rates of tremor (Homberg
et al., 1987). ApEn measurements during sustained sensorimotor
behavior hold promise for determining mechanisms contributing
to tremor in FXTAS, and as surrogate biomarkers useful for
clinical trials targeting tremor in patients (Hagerman et al.,
2012). These findings also may be consistent with our recent
study documenting greater sustained force variability in aging
FMR1 premutation carriers during finger abduction (Park et al.,
2019). While we did not find evidence for atypical variability
in premutation carriers in the present study, we did find that
greater force variability was associated with more severe FXTAS

controls show worsening of their sustained force control as
they age, whereas the opposite pattern is true for premutation
carriers when using the dominant hand. We postulate that older
premutation carriers in our sample who currently report being
asymptomatic may be less affected by aging effects of FMR1
premutation alleles and less likely to develop FXTAS than the
younger individuals in our sample who are beginning to age
into the period of adulthood during which they are most likely
to develop FXTAS symptoms. This hypothesis is supported by
evidence that FXTAS prevalence decreases during late adulthood
reflecting increased FXTAS-related mortality rates and reduced
likelihood of FXTAS onset during elderly years (RodriguezRevenga et al., 2009). Our finding that reduced force complexity
in premutation carriers is more severe at lower force levels
indicates that deficits in sustained sensorimotor behaviors likely
impact multiple tasks of daily living (e.g., lifting a glass of water)
but may not manifest during more strenuous activities involving
higher levels of isometric force.
Reduced complexity of the time-dependent structure of
force oscillations in younger premutation carriers may reflect
a reduced number of neural oscillators (Vaillancourt et al.,
2001b). Neural oscillators within the central nervous system each
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FIGURE 7 | Approximate entropy (ApEn; i.e., force complexity) as a function of group,% MVC, and age (linear fit with 95% confidence intervals). Younger
premutation carriers demonstrated reduced force complexity compared to controls when using their non-dominant hand, but premutation carriers only showed
reduced force complexity compared to controls at younger but not older ages when using their non-dominant hand.

FIGURE 8 | (A) CGG repeat length is associated with reduced dominant hand approximate entropy (ApEn) at 45% MVC. Error bars represent 95% CI of a linear fit.
(B) Increased ICARS rated FXTAS symptoms are associated with longer reaction times (data shown is from rapid test dominant hand trials at 45% MVC). Error bars
represent 95% CI of a linear fit. (C) Increased ICARS rated FXTAS symptoms are associated with increased force variability (force SD) during the non-dominant hand
45% MVC condition. Error bars represent 95% CI of a linear fit.

symptoms suggesting that sustained sensorimotor dysmetria may
be present in aging premutation carriers who are showing or
beginning to show disease-related clinical issues. Ultimately, due
to the relatively small effect sizes of ApEn interactions, it will

Frontiers in Integrative Neuroscience | www.frontiersin.org

be important to systematically assess sustained sensorimotor
control targeting premutation carriers at the younger age
range of our sample (i.e., 45–60 years) and in relation to
FXTAS symptoms over time to determine the power of our
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TABLE 6 | Correlational analyses of CGG and sensorimotor outcomes (Spearman ρ values).

Dominant hand

8 s (“Sustained”)

MVC level

MVC level

Dependent variable

15%

45%

85%

Rise phase reaction time

0.54∗∗

0.37

0.26

Rate of force increase

0.10

0.14

0.15

Rise phase duration
Rise phase accuracy

15%

45%

0.44∗
−0.13

85%

0.12

0.23

0.04

−0.10

0.21

0.13

0.11

0.02

0.12

0.07

−0.09

−0.08

−0.28

0.02

−0.05

−0.01

−0.53∗∗

−0.45∗

ApEn

−

−

−

−0.33

Force SD

−

−

−

0.22

0.19

0.32

Mean force

−

−

−

−0.11

−0.13

−0.16

−0.27

0.12

0.14

Rate of force relaxation
Non-dominant Hand

2 s (“Rapid”)

Rise phase reaction time
Rate of force increase

−0.17

−0.01

−0.08

0.30

0.38

0.40

−0.09

0.02

−0.19

0.09

−0.22

0.46∗

0.45∗

0.36

−0.37

Rise phase duration

0.30 × 10−2

0.06

0.15

0.39

0.35

0.34

Rise phase accuracy

0.17

0.40

−0.07

0.29

0.27

−0.25

ApEn

−

−

−

−0.39

−0.45∗

−0.38

Force SD

−

−

−

0.35

0.18

0.08

Mean force

−

−

−

−0.09

−0.10

−0.07

0.11

0.07

0.22

−0.10

−0.17

0.24

Rate of force relaxation

MVC: maximum voluntary contraction; CGG: cytosine-guanine-guanine; ∗ p < 0.05; ∗∗ p < 0.01. Rates of force relaxation are negative values, and so positive correlations
indicate that an increase in CGG repeat length is associated with slower (i.e., less negative) rates of force relaxation.

TABLE 7 | Correlational analyses of total ICARS scores and sensorimotor outcomes (Spearman ρ values).

Dominant hand

8 s (“Sustained”)

MVC level

MVC level

Dependent variable

15%

45%

85%

15%

Rise phase reaction time

0.52∗

0.70∗∗

0.67∗∗

0.61∗∗

Rate of force increase

0.09

0.11

0.30

−0.09

45%

85%

0.18

0.34

−0.16

0.11

Rise phase duration

−0.05

−0.11

−0.09

−0.21

0.07

0.09

Rise phase accuracy

−0.21

−0.04

−0.23

−0.11

0.12

−0.42

ApEn

−

−

−

−0.18

0.02

−0.20

Force SD

−

−

−

0.22

0.40

0.41

Mean force

−

−

−

0.14

0.08

0.09

−0.27

−0.16

−0.10

Rate of force relaxation
Non-dominant hand

2 s (“Rapid”)

−0.39

Rise phase reaction time

0.46

−0.43

−0.44

0.52∗

0.67∗∗

0.37

0.44

0.25

Rate of force increase

−0.11

−0.04

−0.07

−0.22

−0.05

−0.09

Rise phase duration

−0.22

−0.13

−0.19

−0.20 × 10−2

0.13

−0.20 × 10−2

Rise phase accuracy

−0.10

0.19

0.03

−0.04

0.22

−0.43

−0.17

−0.38

ApEn

−

−

−

−0.40

Force SD

−

−

−

0.34

0.66∗∗

0.58∗

Mean force

−

−

−

0.09

0.14

0.11

0.12

−0.01

0.38

Rate of force relaxation

−0.34

0.02

−0.03

MVC: maximum voluntary contraction; ICARS: International Cooperative Ataxia Rating Scale;
< 0.05;
< 0.01. Rates of force relaxation are negative values, and so
positive correlations indicate that an increase in CGG repeat length is associated with slower (i.e., less negative) rates of force relaxation.
∗p
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ponto-cerebellar functions. The atypical sensorimotor behaviors
identified in this study are consistent with this model and
may serve as objective biobehavioral targets useful for
understanding pathophysiological processes associated with
FXTAS and quantifying clinically relevant changes in aging
premutation carriers.

objective measures of sensorimotor behavior to track FXTAS
progression and risk.

Sensorimotor Behavior and FXTAS
Symptoms
In addition to identifying multiple sensorimotor behavioral
alterations in aging FMR1 premutation carriers, we also
document multiple relationships between sensorimotor
behavior and clinical symptoms of FXTAS. We found that
increased reaction time and increased force variability
each were associated with more severe clinically rated
neuromotor issues in premutation carriers suggesting that
quantifiable deficits in precision sensorimotor behaviors
may be part of the aging process in FMR1 premutation
carriers, or that these issues may reflect early indicators of
neurodegeneration associated with FXTAS. Our findings
that slower reaction times across multiple task conditions
(e.g., target force level, task length, hand) are associated with
more severe clinical symptoms provide evidence that initial
motor preparation and planning processes may deteriorate
as part of the progression of FXTAS. Degeneration of
premotor responses in individuals showing clinical signs
of FXTAS may result from degeneration of motor fiber
tracts that limits rapid processing of sensory information
and generation of action plans (Greco et al., 2006; Wang
et al., 2013). Our finding that greater force variability is
associated with more severe FXTAS symptoms in premutation
carriers indicates that a reduced ability to precisely maintain
a steady motor output in response to sensory feedback
information may track with developing symptoms in
premutation carriers. Increased sustained force variability
also is consistent with known neuropathological indicators
of FXTAS. As individuals sustain a constant level of force
using visual feedback, visual input is translated into motor
corrections through parietal-ponto-cerebellar pathways. The
MCP serves as the primary white matter input pathway
relaying parietal-ponto visual feedback information to
cerebellar circuits that encode reactive motor corrections
to cortex (Stein and Glickstein, 1992). Degeneration of the
MCP, reflected as hyperintensities on T2-weighted scans, is
symptomatic of FXTAS and may contribute to both greater
sensorimotor variability and FXTAS clinical symptoms
(Jacquemont et al., 2003).
Based on prior studies showing that greater CGG repeat
length among premutation carriers increases risk for FXTAS
(Tassone et al., 2007), our finding that reduced ApEn was
related to increased CGG repeat length in premutation carriers
also suggests that sustained sensorimotor behavioral issues
may covary with disease risk. From a more mechanistic
perspective, greater CGG repeat length in the premutation
range contributes to increased mRNA transcript, sequestration
of proteins, and intranuclear inclusions (Greco et al., 2006;
Li and Jin, 2012). These inclusions have been documented
in pontine and cerebellar cells in the majority of cases
studied to date (Greco et al., 2006; Ariza et al., 2016),
suggesting that greater CGG repeat length compromises
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Limitations
Several limitations of the present study should be acknowledged.
First, larger samples of FXTAS patients and asymptomatic
premutation carriers are needed to examine variability in
sensorimotor behavior during aging and determine diseasespecific markers. Longitudinal samples are needed to track
disease onset and progression and clarify the extent to
which objective measures of sensorimotor precision may
track with disease course. Second, it will be important to
include movement disorder comparison groups in future
studies of aging premutation carriers to determine the
specificity of our sensorimotor markers to FMR1 premutation
carriers, though we propose that the next critical step is
to determine the specificity of key sensorimotor issues to
symptomatic compared to asymptomatic FMR1 premutation
carriers so that disease presence can be reliably identified
in aging individuals who test positive for premutation
alleles. Third, our sample consisted primarily of females
who are at reduced risk for FXTAS relative to males.
Despite 75% of our sample being female, we established
multiple sensorimotor issues in aging premutation carriers
and identified multiple participants, both male and female,
showing FXTAS symptoms. Inclusion of females in FXTAS
studies is warranted, though larger samples that allow for
direct comparisons of sensorimotor behavior in aging males
and females are needed. Fourth, while we report behavioral
findings in relation to CGG repeat length, measures of
mRNA, methylation ratios, and FMR protein are important
for clarifying how aberrant neurobiological processes
contribute to FXTAS risk or prodromal symptoms. Last,
as with many hypothesis generating studies, the relatively
small effect sizes of some of our group interactions highlight
the need for replication. Still, our findings identify multiple
sensorimotor targets and highlight important task conditions
and demographic features that can be focused upon (e.g.,
increased sampling of middle-aged carriers) to characterize
neurodegenerative processes associated with FMR1 premutation
alleles and FXTAS.

CONCLUSION
Our results identify multiple precision sensorimotor issues
in aging FMR1 premutation carriers and indicate that select
sensorimotor alterations track with FXTAS symptom severity.
Together, these findings suggest that subclinical deficits of
precision sensorimotor behavior may be detectable prior to the
onset of FXTAS and serve as objective targets for tracking disease
risk and monitoring disease progression.
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